A CU Medicine provider.
Our team is focused on providing comprehensive care for patients with ILD by using a multi-disciplinary and multi-dimensional approach to care and research. Interstitial lung diseases are complex group of more than 100 rare disorders that are often associated with significant morbidity and mortality. Examples of conditions include idiopathic pulmonary fibrosis, rheumatoid arthritis associated ILD and other forms of autoimmune related ILD, and chronic hypersensitivity pneumonitis. Our team has framed our approach to this important patient population by addressing the 4 key areas of clinical care, education of trainees, community outreach, and research.
Qualifications and experience
- Critical Care Medicine, Internal Medicine, Lungs and Breathing, Lungs and Breathing - Interstitial Lung Disease, Pulmonary Disease
- Research interest for patients
Research in my group focuses on advancing the clinical and translational understanding of scarring lung diseases, in particular idiopathic pulmonary fibrosis (IPF) and connective tissue associated interstitial lung disease (ILD). Work in our group encompasses risk factor identification and modification, risk prediction modeling and survival, diagnostic tests, genetics, biomarkers, and quality of life, for both patients and their caregivers. Through our research, I hope to better understand the biological mechanisms and clinical behavior of ILD, and ultimately translate that knowledge into improving patients’ quality of life.
- UCHealth strongly encourages you to consult with your health insurer to determine accurate information about your coverage and benefits for a particular health care service provided at a UCHealth facility. Read more here.